Multi-centred mixed-methods PEPFAR HIV care & support public health evaluation: study protocol

Harding, Richard; Simms, Victoria; Penfold, Suzanne; McCrone, Paul; Moreland, Scott; Downing, Julia; Powell, Richard A.; Mwangi-Powell, Faith; Namisango, Eve; Fayers, Peter; Curtis, Siân; Higginson, Irene J.
January 2010
BMC Public Health;2010, Vol. 10, p584
Academic Journal
Background: A public health response is essential to meet the multidimensional needs of patients and families affected by HIV disease in sub-Saharan Africa. In order to appraise curret provision of HIV care and support in East Africa, and to provide evidence-based direction to future care programming, and Public Health Evaluation was commissioned by the PEPFAR programme of the US Government. Methods/Design: This paper described the 2-Phase international mixed methods study protocol utilising longitudinal outcome measurement, surveys, patient and family qualitative interviews and focus groups, staff qualitative interviews, health economics and document analysis. Aim 1) To describe the nature and scope of HIV care and support in two African countries, including the types of facilities available, clients seen, and availability of specific components of care [Study Phase 1]. Aim 2) To determine patient health outcomes over time and principle cost drivers [Study Phase 2]. The study objectives are as follows. 1) To undertake a cross-sectional survey of service configuration and activity by sampling 10% of the facilities being funded by PEPFAR to provide HIV care and support in Kenya and Uganda (Phase 1) in order to describe care currently provided, including pharmacy drug reviews to determine availability and supply of essential drugs in HIV management. 2) To conduct patient focus group discussions at each of these (Phase 1) to determine care received. 3) To undertake a longitudinal prospective study of 1200 patients who are newly diagnosed with HIV or patients with HIV who present with a new problem attending PEPFAR care and support services. Data collection includes self-reported quality of life, core palliative outcomes and components of care received (Phase 2). 4) To conduct qualitative interviews with staff, patients and carers in order to explore and understand service issues and care provision in more depth (Phase 2). 5) To undertake document analysis to appraise the clinical care procedures at each facility (Phase 2). 6) To determine principle cost drivers including staff, overhead and laboratory costs (Phase 2). Discussion: This novel mixed methods protocol will permit transparent presentation of subsequent dataset results publication, and offers a substantive model of protocol design to measure and integrate key activities and outcomes that underpin a public health approach to disease management in a low-income setting.


Related Articles

  • Health Benefits and Risks of Reporting HIV-Infected Individuals by Name. Colfax, Grant Nash; Bindman, Andrew B. // American Journal of Public Health;Jun98, Vol. 88 Issue 6, p876 

    With more treatment options emerging for human immunodeficiency for human immunodeficiency virus (HIV) infection, the policy of reporting HIV-infected individuals by name merits reevaluation. This paper reviews the benefits and risks of name reporting of persons infected with HIV. Public health...

  • Analysis of how the health systems context shapes responses to the control of human immunodeficiency virus: case-studies from the Russian Federation. Atun, Rifat A.; McKee, Martin; Drobniewski, Francis; Coker, Richard // Bulletin of the World Health Organization;Oct2005, Vol. 83 Issue 10, p730 

    Objective To a methodology and an instrument that allow the simultaneous rapid and systematic examination of the broad public health context, the health care systems, and the features of disease specific programmes. Methods Drawing on methodologies used for rapid situational assessments of...

  • HIV Infection among Low-Risk First Lifetime Testers in Rome, 1990-2000. Galati, V.; Serraino, D.; Puro, V.; Orchi, N.; De Carli, G.; Scognamiglio, P.; Nicastri, E.; Piselli, P.; Nurra, G.; Angeletti, C.; Girardi, E.; Ippolito, G. // Infection;Apr2005, Vol. 33 Issue 2, p61 

    Background: HIV spread among low-risk populations through heterosexual intercourse is a major public health concern. This study was aimed at describing prevalence and determinants of HIV infection among Italian low-risk subjects seeking their first lifetime HIV test. Patients and Methods:...

  • HIV Policy: The Path Forward–A Joint Position Paper of the HIV Medicine Association of the Infectious Diseases Society of America and the American College of Physicians. Lubinski, Christine; Aberg, Judith; Bardeguez, Arlene D.; Elion, Richard; Emmanuel, Patricia; Kuritzkes, Daniel; Saag, Michael; Squires, Kathleen E.; Weddle, Andrea; Rainey, Jennifer; Zerehi, M. Renee; Ralston, J. Fred; Fleming, David A.; Bronson, David; Cooke, Molly; Cutler, Charles; Ejnes, Yul; Gluckman, Robert; Liebow, Mark; Musana, Kenneth // Clinical Infectious Diseases;5/15/2009, Vol. 48 Issue 10, p1335 

    The article offers information on the updated position paper on the policies relating to HIV infection in the U.S. The position paper on HIV policy has been established in collaboration with the HIV Medicine Association of the Infectious Diseases Society of America and the American College of...

  • Genomic Survey of the Non-Cultivatable Opportunistic Human Pathogen, Enterocytozoon bieneusi. Akiyoshi, Donna E.; Morrison, Hilary G.; Shi Lei; Xiaochuan Feng; Quanshun Zhang; Corradi, Nicolas; Mayanja, Harriet; Tumwine, James K.; Keeling, Patrick J.; Weiss, Louis M.; Tzipori, Saul // PLoS Pathogens;Jan2009, Vol. 5 Issue 1, p1 

    Enterocytozoon bieneusi is the most common microsporidian associated with human disease, particularly in the immunocompromised population. In the setting of HIV infection, it is associated with diarrhea and wasting syndrome. Like all microsporidia, E. bieneusi is an obligate, intracellular...

  • STATUS AND TREND OF HIV/AIDS EPIDEMIC IN NEPAL. Joshi, A. B.; Banjara, M. R.; Subedi, B. K.; Sharma, M.; Karki, Y. B. // Journal of the Nepal Medical Association;Sep/Oct2004, Vol. 43 Issue 155, p272 

    The main objective of this study is to review the HIV/AIDS status and trend in Nepal. The design of the study was retrospective in nature. Review was made of published and unpublished documents during the period 1988 to 2004. Year-wise data indicates that the cases of HIV/AIDS have been...

  • Identification of a highly conserved valine-glycine-phenylalanine amino acid triplet required for HIV-1 Nef function. Meuwissen, Pieter J.; Stolp, Bettina; Iannucci, Veronica; Vermeire, Jolien; Naessens, Evelien; Saksela, Kalle; Geyer, Matthias; Vanham, Guido; Arien, Kevin K.; Fackler, Oliver T.; Verhasselt, Bruno // Retrovirology;2012, Vol. 9 Issue 1, p34 

    Background: The Nef protein of HIV facilitates virus replication and disease progression in infected patients. This role as pathogenesis factor depends on several genetically separable Nef functions that are mediated by interactions of highly conserved protein-protein interaction motifs with...

  • HRP-2 determines HIV-1 integration site selection in LEDGF/p75 depleted cells. Schrijvers, Rik; Vets, Sofie; De Rijck, Jan; Malani, Nirav; Bushman, Frederic D.; Debyser, Zeger; Gijsbers, Rik // Retrovirology;2012, Vol. 9 Issue 1, p84 

    Background: Lens epithelium-derived growth factor (LEDGF/p75) is a cellular co-factor of HIV-1 integrase (IN) that tethers the viral pre-integration complex to the host cell chromatin and determines the genome wide integration site distribution pattern of HIV-1. Recently, we demonstrated that...

  • Exploiting the apoptotic process for management of HIV: Are we there yet? Yang, Y.; Ashwell, J. D. // Apoptosis;Feb2001, Vol. 6 Issue 1, p139 

    CD4+ T cells die in individuals infected with HIV, either as a result of direct HIV infection or as uninfected “innocent bystanders”. Possible mechanisms for bystander killing include generation of viral products such as Tat or gp120 and expression of death receptor ligands, such as...


Read the Article


Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics